ITMCTR2200005484尚未招募4 期
Protective effect of Shenxiang Suhe Pill on myocardial ischemia-reperfusion injury and the related mechanism
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 ?(—)
- 性别
- All
入选标准
- •1. Age = 18 years;
- •2. Both groups of patients with MI were patients with acute anterior ST segment elevation myocardial infarction in our hospital. PCI treatment was completed within 12 hours after onset. It was necessary to meet the angiographic diagnosis of total closure of the proximal anterior descending branch, TIMI blood flow grade 0-1, and the proximal anterior descending branch was defined as the end of the left main trunk to the origin of the first diagonal branch;
- •3. The two groups of patients with SPCI were patients with a single proximal anterior descending artery lesion who underwent elective PCI. The proximal segment of the anterior descending artery was defined as the origin from the end of the left main artery to the first diagonal artery. The lesion of the proximal segment of the single anterior descending artery was defined as stenosis = 70% and the degree of stenosis of other coronary artery = 50%;
- •4. The anterior descending artery lesions were successfully opened in all patients. The success criteria were: residual stenosis < 20%, no tear, thrombosis or embolic signs of distal vessels;
- •5. The patient gave informed consent and signed the informed consent form. Be able to participate in outpatient follow-up.
排除标准
- •1. In myocardial infarction group, angiography showed recanalization of anterior descending artery and TIMI blood flow grade 3;
- •2. Received thrombolytic therapy before PCI;
- •3. No previous history of cardiac insufficiency caused by any reason;
- •4. No previous history of structural heart disease, including valvular heart disease, congenital heart disease, pulmonary heart disease, cardiomyopathy, etc;
- •5. No previous myocardial infarction;
- •6. Psychiatric patients;
- •7. Have participated in other clinical trials (just completed or still in progress in recent 2 months);
- •8. Pregnant or lactating women or women planning pregnancy;
- •9. The researcher judged that the compliance of the patient was not good and could not strictly implement the scheme;
- •10. Any other circumstances that the investigator considers unsuitable for participation in the trial.
研究者
相似试验
尚未招募
1 期
Effect of Shenqing capsule on inducing mild to moderate active ulcerative colitis: a multicenter, randomized, double-blinded, parallelly positive controlled studyulcerative colitisITMCTR2000003683onghua Hospital affiliated to Shanghai University of Traditional Chinese Medicine
尚未招募
1 期
Clinical study on the effect of Shengxihuaxian recipe on serum exosome miRNA expression profile in patients with Idiopathic pulmonary fibrosis diseaseIDiopathic pulmonary fibrosisITMCTR2200006584Affiliated Hospital of Gansu University of Traditional Chinese medicine
尚未招募
4 期
Clinical Trial of Suxiao Jiuxin Pill to Protect Endothelial Function in Patients With Acute Coronary SyndromeAcute coronary syndromeITMCTR2100005344The second affiliated hospital of guangzhou university of traditional Chinese medicine Hospital guangzhou
尚未招募
1 期
A clinical study of Protective effect of Fu's Subcutaneous Needling intervention on diaphragmatic function in patients with severe stroke under mechanical ventilatioITMCTR2100005259Shandong Provincial Third Hospital
招募中
不适用
Clinical study on the effect of Sansang Shenqi Decoction on airway function in patients with chronic obstructive pulmonary disease at stable periodITMCTR2000003723ongHua Hospital Shanghai University of Traditional Chinese Medicine
